Olorofim

Active substance

F901318

Holder

F2G Ltd

Status

closed

Indication

Treatment of invasive fungal infections due to Lomentospora prolificans, Scedosporium spp., Aspergillus spp., and other resistant fungi in patients lacking suitable alternative treatment.

Public documents

Approbation

Information for the patient

Informed consent

Last update

23/06/2023